Outcomes

Duxlink Health, through its research, has shown how the H2C2 has benefitted the healthcare industry as a whole, when compared to conventional care for High Risk Patients. Notably, in all areas examined there has been 75+% improvement when it comes to costs, reduction in admissions, and in the occurrences of MACE (Major Adverse Cardiovascular Events). There will be a presentation held at the American College of Cardiology (ACC) National Conference discussing this groundbreaking study.

 

N=54 Conventional Care Duxlink HRC Tele-Hospital Improvement P-Value

Total MACE - Quality

32

4*

87.5%

p=0.001

# Total Hospital Admissions/ER - Cost

104

24*

76.9%

p < 0.0001

Normalized Admissions/Patient

2.06 ± 0.37

0.47 ± 0.18*

77.2%

p < 0.0001

Total 3-Month Cost

$1,395,000

$345,000*

75.3%

p < 0.0001

Net saving over 3 Month $1.05M and Annualized Savings ~$4M